# Stereotactic Radiotherapy in Association With Immunotherapy for the Treatment of NSCLC Brain Metastases

> **NCT04787185** · — · UNKNOWN · sponsor: **Azienda Ospedaliero-Universitaria Careggi** · enrollment: 50 (estimated)

## Conditions studied

- Brain Metastases From NSCLC

## Interventions

- **RADIATION:** Valutation of toxicity

## Key facts

- **NCT ID:** NCT04787185
- **Lead sponsor:** Azienda Ospedaliero-Universitaria Careggi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-17
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04787185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04787185, "Stereotactic Radiotherapy in Association With Immunotherapy for the Treatment of NSCLC Brain Metastases". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04787185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*